Videos

On September 21, 2022, I presented an overview of key abstracts on biliary tract cancer (BTC) presented at the 2022 annual meeting of the European Society for Medical Oncology (ESMO 2022). In addition, I provided my perspective on the impact of the data on the management of patients with BTC.

Angela Lamarca, MD, PhD, MSc, Consultant (FEA) in Medical Oncology presents an overview of key abstracts on cholangiocarcinoma (CCA) presented at the 2022 annual meeting of the ESMO World Congress on Gastrointestinal Cancer (ESMO GI 2022).

Dr Abou-Alfa also provides his perspective on the impact of the data on the management of patients with CCA.

Flavio Rocha, MD, FACS, FSSO, the Hedinger Chair of Surgical Oncology and Physician-in-Chief of the Knight Cancer Institute at Oregon Health & Science University, presents an overview of the key abstracts on cholangiocarcinoma and gallbladder cancer presented at the 2022 annual meeting of IHPBA. Dr Rocha also provides his perspectives on the clinical impact of the data on patient outcomes.

Dr Milind Javle provides his perspectives on key presentations on cholangiocarcinoma and biliary tract cancer at the 2022 ASCO Gastrointestinal Cancers Symposium.

Dr Virote Sriuranpong provides a perspective on key issues facing Thailand and other Asian countries in the prevention, screening, and early diagnosis of CCA.

Drs Keri Lunsford and Alice Wei provide their perspectives on how the molecular profile of iCCA patients can help direct surgery and locoregional therapy.

Dr Cristina Ferrone discusses the use of adjuvant therapy, and Dr Shishir Kumar Maithel speaks to the role of neoadjuvant therapy in patients with iCCA.

Drs Alice Wei and Skye Mayo discuss options for induction therapy prior to surgery in iCCA.